share_log

This Cytokinetics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

このサイトカイネティックスのアナリストが強気の見通しでカバレッジを開始します。こちらは金曜日のトップ5の初期値です。

Benzinga ·  11/08 08:42

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

  • Guggenheim analyst Seamus Fernandez initiated coverage on Cidara Therapeutics, Inc. (NASDAQ:CDTX) with a Buy rating and announced a price target of $33. Cidara Therapeutics shares closed at $13.11 on Thursday. See how other analysts view this stock.
  • RBC Capital analyst Leonid Timashev initiated coverage on Cytokinetics, Incorporated (NASDAQ:CYTK) with an Outperform rating and announced a price target of $80. Cytokinetics shares closed at $55.84 on Thursday. See how other analysts view this stock.
  • Stephens & Co. analyst Sudan Loganathan initiated coverage on Immunome, Inc. (NASDAQ:IMNM) with an Overweight rating and announced a price target of $30. Immunome shares closed at $12.54 on Thursday. See how other analysts view this stock.
  • Jefferies analyst Dennis Ding initiated coverage on Inhibikase Therapeutics, Inc. (NASDAQ:IKT) with a Buy rating and announced a price target of $8. Inhibikase Therapeutics shares closed at $2.78 on Thursday. See how other analysts view this stock.
  • UBS analyst Ben Shelley initiated coverage on Flutter Entertainment plc (NYSE:FLUT) with a Buy rating and announced a price target of $306. Flutter Entertainment shares closed at $237.98 on Thursday. See how other analysts view this stock.

Considering buying CYTK stock? Here's what analysts think:

big

Read More:

  • How To Earn $500 A Month From Nvidia Stock After Trump Win
これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする